Hayes Don, Glanville Allan R, McGiffin David, Tobias Joseph D, Tumin Dmitry
Departments of Pediatrics, Internal Medicine, and Surgery.
Department of Thoracic Medicine, The Lung Transplant Unit, St. Vincent׳s Hospital, Darlinghurst, New South Wales, Australia.
J Heart Lung Transplant. 2016 Sep;35(9):1108-15. doi: 10.1016/j.healun.2016.04.015. Epub 2016 May 6.
A survival advantage has been demonstrated for lung transplantation (LTx) in the cystic fibrosis (CF) population, but children may be at higher risk of post-transplant mortality than adults.
The registry of the International Society for Heart and Lung Transplantation (ISHLT) was queried for lung transplants performed during the period 1998 to 2014 in patients with CF. Period differences were assessed by dividing the sample into LTxs performed between 2006 and 2014 and those performed between 1998 and 2005. Age ≥18 years distinguished adult from pediatric recipients. Supplemental analyses of United States of America (USA) LTx recipients with CF utilized 1998 to 2014 data from the United Network for Organ Sharing (UNOS) registry.
A total of 7,245 patients from the ISHLT registry were selected for analysis. Kaplan-Meier curves confirmed a survival disadvantage of children as compared to adults with CF in 2006 to 2014 (p<0.001), and in the earlier era of 1998 to 2005 (p = 0.002). Univariate Cox proportional hazards regression revealed that age <18 years at transplantation [hazard ratio (HR) = 1.367; 95% confidence interval (CI) 1.225 to 1.526; p < 0.001] and LTxs performed in 1998 to 2005 (HR = 1.131; 95% CI 1.042 to 1.227; p = 0.003) were associated with greater mortality hazard. Multivariable Cox regression adjusting for potential confounders and interacting LTx era with recipient age group confirmed the persistence of age-related survival disparities after LTx in CF in the contemporary era. Analysis of UNOS data demonstrated survival disparities between children and adult CF patients receiving LTx in majority-adult programs.
An age-related survival disparity after LTx has persisted in the international CF population. Data from the USA suggest this disparity is not fully explained by differences in center volume between adult and pediatric programs in the contemporary era.
肺移植(LTx)已被证明对囊性纤维化(CF)患者有生存优势,但儿童移植后死亡风险可能高于成人。
查询国际心肺移植学会(ISHLT)登记处1998年至2014年期间对CF患者进行的肺移植情况。通过将样本分为2006年至2014年进行的肺移植和1998年至2005年进行的肺移植来评估不同时期的差异。年龄≥18岁区分成人和儿童受者。对美国CF肺移植受者的补充分析利用了器官共享联合网络(UNOS)登记处1998年至2014年的数据。
共从ISHLT登记处选择了7245例患者进行分析。Kaplan-Meier曲线证实,在2006年至2014年期间,与CF成人患者相比,儿童患者存在生存劣势(p<0.001),在1998年至2005年的早期也是如此(p = 0.002)。单因素Cox比例风险回归显示,移植时年龄<18岁[风险比(HR)= 1.367;95%置信区间(CI)1.225至1.526;p < 0.001]以及1998年至2005年进行的肺移植(HR = 1.131;95%CI 1.042至1.227;p = 0.003)与更高的死亡风险相关。多因素Cox回归在调整潜在混杂因素并将肺移植时期与受者年龄组进行交互分析后,证实了当代CF患者肺移植后与年龄相关的生存差异仍然存在。对UNOS数据的分析表明,在以成人为主的项目中,接受肺移植的儿童和成人CF患者之间存在生存差异。
肺移植后与年龄相关的生存差异在国际CF患者群体中仍然存在。美国的数据表明,当代成人和儿童项目中心容量的差异并不能完全解释这种差异。